Advertisement

Neurosyphilis

Chapter

Abstract

Involvement of the central nervous system (CNS) may occur at all stages of syphilis. It can be assigned to primosecondary stage, early and late latency, or tertiary stage according to the interval after infection and the symptomatology. CNS involvement in early syphilis manifests as mild meningitis, cranial nerve alterations, and vascular brainstem syndromes. Syphilitic polyradiculitis also develops during the secondary stage. “Asymptomatic neurosyphilis,” syphilitic amyotrophia, as well as pachymeningitis cervicalis hyperplastica, which are very rare at present, are primarily diagnosed in the stage of late latency. Typical CNS manifestations of tertiary syphilis are meningovascular neurosyphilis, tabes dorsalis, and general paresis. Syphilitic CNS involvement is verified by pathologic cerebrospinal fluid (CSF) findings showing the constellation of a chronic inflammatory CNS process, and by the proof of intrathecal synthesis of specific antibodies against Treponema pallidum demonstrated by an antibody index (ITpA index  ³  3). First-choice therapeutic measures are infusions of high-dose penicillin G (18–30 mio IU/day). Coinfections of syphilis and human immunodeficiency virus (HIV) are characterized by complicated courses of disease. Close-meshed control examinations and longer follow-up are necessary in such cases.

Keywords

Human Immunodeficiency Virus Central Nervous System Involvement Central Nervous System Symptom Venereal Disease Research Laboratory Early Syphilis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1.  1.
    Bracero, I., Wormser, G.P., Bottone, E.J.: Serologic tests for syphilis: a guide to interpretation in various states of disease. Mt. Sinai J. Med. 46, 289–292 (1979)PubMedGoogle Scholar
  2.  2.
    Burke, J.M., Schaberg, D.R.: Neurosyphilis in the antibiotic era. Neurology 35, 1368–1371 (1985)PubMedGoogle Scholar
  3.  3.
    Centers for Disease Control and Prevention: Sexually transmitted disease treatment guidelines. MMWR Morb. Mortal Wkly Rep. 55, 40–43 (2006)Google Scholar
  4.  4.
    Clark, E.G., Danbolt, N.: The Oslo study of the natural history of untreated syphilis. J. Chron. Dis. 2, 311–344 (1955)PubMedCrossRefGoogle Scholar
  5.  5.
    Clinical Effectiveness Group: UK national guidelines for the management of late syphilis. http://www.bashh.org/guidelins.asp (2002).
  6.  6.
    Engelkens, H.J.H., ten Kate, F.J.W., Judanarso, J., et al.: The localisation of treponemes and characterisation of the inflammatory infiltrate in skin biopsies from patients with primary or secondary syphilis, or early infectious yaws. Genitourin. Med. (England) 69, 102–107 (1993)Google Scholar
  7.  7.
    Fox, P.A., Hawkin, D.A., Dawson, D.: Dementia following an acute presentation of meningovascular neurosyphilis in an HIV-1 positive patient. AIDS 14, 2062–2063 (2000)PubMedCrossRefGoogle Scholar
  8.  8.
    Goh, B., Smith, G.W., Samarasinghe, L., et al.: Penicillin concentrations in serum and cerebrospinal fluid after intramuscular injection of aqueous procaine penicillin 0.6 MU with and without probenecid. Br. J. Vener. Dis. 60, 371–373 (1984)PubMedGoogle Scholar
  9.  9.
    Gordon, S.M., Eaton, M.E., George, R., et al.: The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with HIV infection. N Engl. J. Med. 331, 1469–1473 (1994)PubMedCrossRefGoogle Scholar
  10. 10.
    Hook, E.W., Marra, C.: Acquired syphilis in adults. N Engl. J. Med. 326, 1060–1069 (1992)PubMedCrossRefGoogle Scholar
  11. 11.
    Hooshmand, H., Escobar, M.R., Kopf, S.W.: Neurosyphilis. A study of 241 patients. JAMA 219, 726–729 (1972)PubMedCrossRefGoogle Scholar
  12. 12.
    Hutchinson, J.: Disease of the Eye and Ear Consequent upon Inherited Syphilis. Churchill, London (1863)Google Scholar
  13. 13.
    Idsøe, O., Guthe, T., Willcox, R.R.: Penicillin in the treatment of syphilis. The experience of three decades. Bull. World Health Organ. 47(Suppl), 1–68 (1972)PubMedGoogle Scholar
  14. 14.
    Korting, H.C., Walther, G., Riethmüller, U., et al.: Comparative in vivo susceptibility of Treponema pallidum to ceftizoxime, ceftriaxone and penicillin G. Chemotherapy 32, 352–355 (1986)PubMedCrossRefGoogle Scholar
  15. 15.
    Löwhagen, G.B., Andersen, M., Blomstrand, C., et al.: Central nervous system involvement in early syphilis. Acta Derm. Venereol. (Stockholm) 63, 409–417 (1983)Google Scholar
  16. 16.
    Lukehart, S.A., Hook, E.W., Baker-Zander, S.A., et al.: Invasion of the central nervous system by Treponema pallidum. Ann. Intern. Med. 109, 855–862 (1988)PubMedGoogle Scholar
  17. 17.
    Marra, C.M., Gary, D.W., Kuypers, J. et al.: Diagnosis of neurosyphilis in patients infected with human immunodeficiency virus type 1. J. Infect. Dis. 174, 219–221 (1996)PubMedCrossRefGoogle Scholar
  18. 18.
    Marra, C.M., Boutin, P., McArthur, J.C., et al.: A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin. Infect. Dis. 30, 540–544 (2000)PubMedCrossRefGoogle Scholar
  19. 19.
    Mohr, J.A., Griffiths, W., Jackson, R., et al.: Neurosyphilis and penicillin levels in cerebrospinal fluid. JAMA 236, 2208–2209 (1976)PubMedCrossRefGoogle Scholar
  20. 20.
    Moore, J.E., Faupel, M.: Asymptomatic neurosyphilis. A comparison of early and late asymptomatic neurosyphilis. Arch. Dermatol. Syph. 18, 99–108 (1928)Google Scholar
  21. 21.
    Moore, J.E., Hopkins, H.H.: Asymptomatic neurosyphilis. VI. The prognosis of early and late asymptomatic neurosyphilis. JAMA 95, 1637–1641 (1930)Google Scholar
  22. 22.
    Nau, R., Prange, H.W., Muth, P., et al.: Passage of cefotaxime and ceftriaxone into the cerebrospinal fluid of patients with uninflamed meninges. Antimicrob. Agents Chemother. 27, 1518–1524 (1993)Google Scholar
  23. 23.
    Prange, H.: Neurosyphilis. VCH Verlag, Weinheim (1987)Google Scholar
  24. 24.
    Prange, H.W., Moskophidis, M., Schipper, H., et al.: Relationship between neurological features and intrathecal synthesis of IgG antibodies to Treponema pallidum. J. Neurol. 230, 241–252 (1983)PubMedCrossRefGoogle Scholar
  25. 25.
    Prange, H.W., Bobis-Seidenschwanz, I.: Zur Evaluierung serologischer Aktivitätskriterien bei Neurosyphilis. Verh. Dtsch. Ges. Neurol. 8, 789–791 (1994/95)Google Scholar
  26. 26.
    Quinn, T.C., Bender, B.: Sexually transmitted diseases. In: Harvey, A.M., Johns, R.J. (eds.) The Principles and Practice of Medicine, 22nd edn, pp. 661–663. Appleton & Lange, Norwalk (1988)Google Scholar
  27. 27.
    Reiber, H., Lange, P.: Quantification of virus-specific antibodies in cerebrospinal fluid and serum. Clin. Chem. 37, 1153–1160 (1991)PubMedGoogle Scholar
  28. 28.
    Rein, M.: Treatment of neurosyphilis. JAMA 246, 2613–2614 (1981)PubMedCrossRefGoogle Scholar
  29. 29.
    Robert-Koch-Institut: Syphilis in Deutschland. Neurosyphilis – Fallbericht, Bedeutung, Diagnostik und Prävention. Epidemiol. Bull. 5, 35–36 (2002)Google Scholar
  30. 30.
    Robert-Koch-Institut: Syphilis in Deutschland. Berichtsmonat Juli. Epidemiol. Bull. 29, 257 (2007)Google Scholar
  31. 31.
    Secher, L., Weismann, K., Kobayshi, T.: Treponema pallidum in peripheral nerve tissue of syphilitic chancre. Acta Derm. Veneral. (Stockholm) 62, 407–411 (1982)Google Scholar
  32. 32.
    Silberstein, P., Lawrence, R., Pryor, D., et al.: A case of neurosyphilis with florid Jarisch-Herxheimer reaction. J. Clin. Neurosci. 9, 689–690 (2002)PubMedCrossRefGoogle Scholar
  33. 33.
    Volles, E., Ritter, G.: Zur Penicillin-Behandlung der Neurolues unter pharmakokinetischem Aspekt. Z. Neurol. 206, 235–242 (1974)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Berlin Heidelberg 2011

Authors and Affiliations

  1. 1.Neurologische Universitätsklinik GöttingenGöttingenGermany

Personalised recommendations